Comparison of Four SARS-CoV-2 Neutralization Assays.

SARS-CoV-2 neutralization assay neutralizing antibodies pseudotype virus

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
28 Dec 2020
Historique:
received: 27 11 2020
revised: 18 12 2020
accepted: 20 12 2020
entrez: 31 12 2020
pubmed: 1 1 2021
medline: 1 1 2021
Statut: epublish

Résumé

Neutralizing antibodies are a major correlate of protection for many viruses including the novel coronavirus SARS-CoV-2. Thus, vaccine candidates should potently induce neutralizing antibodies to render effective protection from infection. A variety of in vitro assays for the detection of SARS-CoV-2 neutralizing antibodies has been described. However, validation of the different assays against each other is important to allow comparison of different studies. Here, we compared four different SARS-CoV-2 neutralization assays using the same set of patient samples. Two assays used replication competent SARS-CoV-2, a focus forming assay and a TCID

Identifiants

pubmed: 33379160
pii: vaccines9010013
doi: 10.3390/vaccines9010013
pmc: PMC7824240
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
Science. 2020 Nov 13;370(6518):856-860
pubmed: 33082293
J Virol. 2009 May;83(10):4844-53
pubmed: 19279116
Clin Microbiol Infect. 2020 Oct;26(10):1386-1394
pubmed: 32603801
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Clin Infect Dis. 2020 Aug 25;:
pubmed: 32840608
Clin Infect Dis. 2020 Sep 23;:
pubmed: 32964927
Emerg Microbes Infect. 2020 Dec;9(1):680-686
pubmed: 32207377
Vaccines (Basel). 2020 Jul 15;8(3):
pubmed: 32679691
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Virus Res. 2011 Sep;160(1-2):283-93
pubmed: 21798295
Elife. 2020 Oct 28;9:
pubmed: 33112236
Curr Protoc Microbiol. 2020 Sep;58(1):e108
pubmed: 32585083
J Virol. 2004 Sep;78(17):9007-15
pubmed: 15308697
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32692348
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
Science. 2020 Aug 21;369(6506):1014-1018
pubmed: 32540904
J Gen Virol. 2020 Aug;101(8):791-797
pubmed: 32430094
J Virol. 2014 May;88(9):4897-907
pubmed: 24554655
Sci Transl Med. 2020 Sep 2;12(559):
pubmed: 32817357
Infection. 2020 Aug 21;:
pubmed: 32827125
Viruses. 2020 May 06;12(5):
pubmed: 32384820
J Gen Virol. 2010 Nov;91(Pt 11):2782-93
pubmed: 20631091

Auteurs

Lydia Riepler (L)

Department of Hygiene, Microbiology and Public Health, Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Annika Rössler (A)

Department of Hygiene, Microbiology and Public Health, Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Albert Falch (A)

Department of Hygiene, Microbiology and Public Health, Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

André Volland (A)

Department of Hygiene, Microbiology and Public Health, Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Wegene Borena (W)

Department of Hygiene, Microbiology and Public Health, Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Dorothee von Laer (D)

Department of Hygiene, Microbiology and Public Health, Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Janine Kimpel (J)

Department of Hygiene, Microbiology and Public Health, Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Classifications MeSH